NANOVIRICIDES, INC. FY 2026: Revenue $0 EPS ($0.41) — 10-K Summary
NANOVIRICIDES, INC. reported fiscal 2026 results in its 10-K showing no revenue for the year and a net loss of $8.22M, an improvement from a $9.47M loss in FY 2025; diluted loss per share was $0.41 in FY 2026 versus $0.63 in FY 2025.Financial HighlightsBusiness HighlightsOriginal SEC Filing: NANOVI…